NLRP3 and inflammatory bowel disease: For example, Ke et al. (2016) demonstrated that activating CB2 alleviated inflammatory bowel disease in mice models via the inhibition of the NLRP3 inflammasome by inducing autophagy process in murine macrophages (Ke et al., 2016).